Evidence map›Paper›PMID 40543043›Full record

ArticleCancer cytopathology2025

Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System.

Esther Elishaev, Lakshmi Harinath, Yuhong Ye, Jonee Matsko, Amy Colaizzi, Stephanie Wharton, Rohit Bhargava, Liron Pantanowitz, Matthew G Hanna, Sarah Harrington and 1 more

Abstract read
In one paragraph

Article in Cancer cytopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. How to evaluate and select cervical screening and triage tests in vaccinated populations.Journal of the National Cancer Institute. Monographs · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Esther ElishaevDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-6271-0222
Lakshmi HarinathDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-6472-732X
Yuhong YeDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Jonee MatskoDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Amy ColaizziDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Stephanie WhartonDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Rohit BhargavaDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Liron PantanowitzDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-8182-5503
Matthew G HannaDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Sarah HarringtonScientific Affairs, Hologic, Inc, Marlborough, Massachusetts, USA.
Chengquan ZhaoDepartment of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-7524-3048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedical technologies powered by artificial intelligence are quickly transforming into practical solutions by rapidly leveraging massive amounts of data processed via deep learning algorithms. There is a necessity to validate these innovative tools when integrated into clinical practice.

methodsThis study evaluated the performance of the Hologic Genius Digital Diagnostics System (HGDDS) with a cohort of 890 previously reviewed and diagnosed ThinPrep Papanicolaou (Pap) tests with the intent to deploy this system for routine clinical use. The study included all diagnostic categories of The Bethesda System, with follow-up tissue sampling performed within 6 months of abnormal Pap test results to serve as the ground truth.

resultsThe HGDDS demonstrated excellent performance in detecting significant Pap test findings, with close to 100% sensitivity (98.2%-100%) for cases classified as atypical squamous cells of undetermined significance and above within a 95% confidence interval and a high negative predictive value (92.4%-100%).

conclusionsThe HGDDS streamlined workflow, reduced manual workload, and functioned as a stand-alone system.

Indexed as

Atypical Squamous Cells of the CervixEarly Detection of CancerPapanicolaou TestUterine Cervical NeoplasmsAdultArtificial IntelligenceCytodiagnosisFemaleHumansMiddle AgedSensitivity and SpecificityVaginal Smearsartificial intelligencecytologydeep learningPapanicolaou (Pap test)screeningThinPrep

Identifiers

PMID40543043
PMCPMC12182264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.